{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:46:45Z","timestamp":1790084805759,"version":"4.0.1"},"reference-count":156,"publisher":"Oxford University Press (OUP)","issue":"36","license":[{"start":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T00:00:00Z","timestamp":1780617600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Leonie-Wild Foundation"},{"name":"Leyla Erkan Family Fund for ARVD Research"},{"name":"Hugh Calkins, Marvin H. Weiner, and Jacqueline J. Bernstein Cardiac Arrhythmia Center"},{"name":"Dr Francis P. Chiramonte Private Foundation"},{"name":"Bogle Foundation"},{"DOI":"10.13039\/501100019817","name":"Peter French Memorial Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019817","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,9,22]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Arrhythmogenic cardiomyopathy (ACM) is a form of inheritable cardiomyopathy characterized by ventricular scarring and\/or fibro-fatty replacement. ACM is associated with a significant risk of sudden cardiac death due to ventricular arrhythmias, especially in young patients and endurance athletes. Aim of this review is to summarize the changing in understanding and framing of this multifaceted disease, in particular highlighting the current transition from a phenotype-first to a genotype-first framework for diagnosis and management.<\/jats:p>","DOI":"10.1093\/eurheartj\/ehag297","type":"journal-article","created":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T11:28:04Z","timestamp":1775561284000},"page":"5072-5088","source":"Crossref","is-referenced-by-count":1,"title":["Arrhythmogenic right ventricular cardiomyopathy"],"prefix":"10.1093","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3432-070X","authenticated-orcid":false,"given":"Alessio","family":"Gasperetti","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University , 600 N. Wolfe St. Blalock 545, Baltimore, MD 21784 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0854-0418","authenticated-orcid":false,"given":"Cynthia A","family":"James","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University , 600 N. Wolfe St. Blalock 545, Baltimore, MD 21784 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4748-0158","authenticated-orcid":false,"given":"Firat","family":"Duru","sequence":"additional","affiliation":[{"name":"Division of Cardiology, University Hospital of Zurich , Zurich ,","place":["Switzerland"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van Tintelen","sequence":"additional","affiliation":[{"name":"Department of Genetics, University Medical Center Utrecht , Utrecht ,","place":["The Netherlands"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9262-9433","authenticated-orcid":false,"given":"Hugh","family":"Calkins","sequence":"additional","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Johns Hopkins University , 600 N. Wolfe St. Blalock 545, Baltimore, MD 21784 ,","place":["USA"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,5]]},"reference":[{"key":"2026092119581407600_ehag297-B1","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","article-title":"2023 ESC guidelines for the management of cardiomyopathies","volume":"44","author":"Arbelo","year":"2023","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B2","doi-asserted-by":"publisher","first-page":"e301","DOI":"10.1016\/j.hrthm.2019.05.007","article-title":"2019 HRS expert consensus statement on evaluation, risk stratification, and management of arrhythmogenic cardiomyopathy","volume":"16","author":"Towbin","year":"2019","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B3","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.jacep.2021.12.002","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"8","author":"Krahn","year":"2022","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119581407600_ehag297-B4","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1016\/j.jacc.2016.02.062","article-title":"Etiology of sudden death in sports: insights from a United Kingdom regional registry","volume":"67","author":"Finocchiaro","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B5","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1093\/eurheartj\/ehaa821","article-title":"Arrhythmogenic right ventricular cardiomyopathy and sports activity: from molecular pathways in diseased hearts to new insights into the athletic heart mimicry","volume":"42","author":"Gasperetti","year":"2021","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B6","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1056\/NEJM198801213180301","article-title":"Right ventricular cardiomyopathy and sudden death in young people","volume":"319","author":"Thiene","year":"1988","journal-title":"N Engl J Med"},{"key":"2026092119581407600_ehag297-B7","doi-asserted-by":"publisher","first-page":"1887","DOI":"10.1161\/CIRCRESAHA.116.304521","article-title":"The Spectrum of epidemiology underlying sudden cardiac death","volume":"116","author":"Hayashi","year":"2015","journal-title":"Circ Res"},{"key":"2026092119581407600_ehag297-B8","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1056\/NEJMra1509267","article-title":"Arrhythmogenic right ventricular cardiomyopathy","volume":"376","author":"Corrado","year":"2017","journal-title":"N Engl J Med"},{"key":"2026092119581407600_ehag297-B9","doi-asserted-by":"publisher","first-page":"1995","DOI":"10.1016\/j.jacc.2022.09.018","article-title":"Genotype-based risk stratification can outperform phenotype-based practice for inherited cardiomyopathies","volume":"80","author":"James","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B10","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.hrthm.2024.01.045","article-title":"Disputation on the power and efficacy of phenotypical classification in arrhythmogenic cardiomyopathy: time for a reformation?!","volume":"21","author":"Gasperetti","year":"2024","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B11","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1161\/01.CIR.65.2.384","article-title":"Right ventricular dysplasia: a report of 24 adult cases","volume":"65","author":"Marcus","year":"1982","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1136\/hrt.56.4.321","article-title":"Cardiac abnormalities in familial palmoplantar keratosis","volume":"56","author":"Protonotarios","year":"1986","journal-title":"Br Heart J"},{"key":"2026092119581407600_ehag297-B13","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1136\/hrt.71.3.215","article-title":"Diagnosis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy. Task force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of cardiology","volume":"71","author":"McKenna","year":"1994","journal-title":"Br Heart J"},{"key":"2026092119581407600_ehag297-B14","doi-asserted-by":"publisher","first-page":"2119","DOI":"10.1016\/S0140-6736(00)02379-","article-title":"Identification of a deletion in plakoglobin in arrhythmogenic right ventricular cardiomyopathy with palmoplantar keratoderma and woolly hair (Naxos disease)","volume":"355","author":"McKoy","year":"2000","journal-title":"Lancet"},{"key":"2026092119581407600_ehag297-B15","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1086\/344208","article-title":"Mutation in human desmoplakin domain binding to plakoglobin causes a dominant form of arrhythmogenic right ventricular cardiomyopathy","volume":"71","author":"Rampazzo","year":"2002","journal-title":"Am J Hum Genet"},{"key":"2026092119581407600_ehag297-B16","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1038\/ng1461","article-title":"Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy","volume":"36","author":"Gerull","year":"2004","journal-title":"Nat Genet"},{"key":"2026092119581407600_ehag297-B17","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1161\/CIRCULATIONAHA.105.583674","article-title":"Mutations in desmoglein-2 gene are associated with arrhythmogenic right ventricular cardiomyopathy","volume":"113","author":"Pilichou","year":"2006","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B18","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1086\/509122","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy associated with mutations in the desmosomal gene desmocollin-2","volume":"79","author":"Syrris","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2026092119581407600_ehag297-B19","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1093\/eurheartj\/ehq025","article-title":"Diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: proposed modification of the task force criteria","volume":"31","author":"Marcus","year":"2010","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B20","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ajhg.2008.01.010","article-title":"Arrhythmogenic right ventricular cardiomyopathy type 5 is a fully penetrant, lethal arrhythmic disorder caused by a missense mutation in the TMEM43 gene","volume":"82","author":"Merner","year":"2008","journal-title":"Am J Hum Genet"},{"key":"2026092119581407600_ehag297-B21","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.hrthm.2010.04.023","article-title":"Desmin mutations as a cause of right ventricular heart failure affect the intercalated disks","volume":"7","author":"Otten","year":"2010","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B22","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1161\/CIRCGENETICS.113.000374","article-title":"Outcome in phospholamban R14del carriers: results of a large multicentre cohort study","volume":"7","author":"Van Rijsingen","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"2026092119581407600_ehag297-B23","doi-asserted-by":"publisher","first-page":"2440","DOI":"10.1016\/j.jacc.2016.09.927","article-title":"Truncating FLNC mutations are associated with high-risk dilated and arrhythmogenic cardiomyopathies","volume":"68","author":"Ortiz-Genga","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B24","doi-asserted-by":"publisher","first-page":"1850","DOI":"10.1093\/eurheartj\/ehz103","article-title":"A new prediction model for ventricular arrhythmias in arrhythmogenic right ventricular cardiomyopathy","volume":"40","author":"Cadrin-Tourigny","year":"2019","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B25","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1161\/CIRCULATIONAHA.119.044934","article-title":"Desmoplakin cardiomyopathy, a fibrotic and inflammatory form of cardiomyopathy distinct from typical dilated or arrhythmogenic right ventricular cardiomyopathy","volume":"141","author":"Smith","year":"2020","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B26","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.ijcard.2020.06.005","article-title":"Diagnosis of arrhythmogenic cardiomyopathy: the Padua criteria","volume":"319","author":"Corrado","year":"2020","journal-title":"Int J Cardiol"},{"key":"2026092119581407600_ehag297-B27","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1161\/CIRCULATIONAHA.124.072226","article-title":"Natural history and clinical outcomes of patients with DSG2\/DSC2 variant-related arrhythmogenic right ventricular cardiomyopathy","volume":"151","author":"Chen","year":"2025","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B28","doi-asserted-by":"publisher","first-page":"2968","DOI":"10.1093\/eurheartj\/ehae409","article-title":"A novel tool for arrhythmic risk stratification in desmoplakin gene variant carriers","volume":"45","author":"Carrick","year":"2024","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B29","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jamacardio.2024.5543","article-title":"Arrhythmic risk stratification of carriers of Filamin C truncating variants","volume":"10","author":"Filamin C Registry Consortium","year":"2025","journal-title":"JAMA Cardiol"},{"key":"2026092119581407600_ehag297-B30","doi-asserted-by":"publisher","first-page":"1600","DOI":"10.1161\/CIRCULATIONAHA.121.053521","article-title":"Phenotypic expression, natural history, and risk stratification of cardiomyopathy caused by Filamin C truncating variants","volume":"144","author":"Gigli","year":"2021","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B31","volume-title":"De Motu Cordis et Aneurysmatibus","author":"Lancisi","year":"1736"},{"key":"2026092119581407600_ehag297-B32","volume-title":"De L\u2019auscultation M\u00e9diate ou Trait\u00e9 du Diagnostic des Maladies des Poumons et du Coeur","author":"Laennec","year":"1816"},{"key":"2026092119581407600_ehag297-B33","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1093\/eurheartj\/ehab294","article-title":"Prediction of ventricular arrhythmia in phospholamban p.Arg14del mutation carriers\u2013reaching the frontiers of individual risk prediction","volume":"42","author":"Verstraelen","year":"2021","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B34","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1016\/j.jacc.2008.09.019","article-title":"Left-dominant arrhythmogenic cardiomyopathy","volume":"52","author":"Sen-Chowdhry","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B35","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.1161\/CIRCULATIONAHA.118.037230","article-title":"Sudden death and left ventricular involvement in arrhythmogenic cardiomyopathy","volume":"139","author":"Miles","year":"2019","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B36","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.ahj.2020.01.019","article-title":"Clinical predictors of left ventricular involvement in arrhythmogenic right ventricular cardiomyopathy","volume":"223","author":"Akdis","year":"2020","journal-title":"Am Heart J"},{"key":"2026092119581407600_ehag297-B37","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1093\/europace\/euz352","article-title":"Long-term follow-up analysis of a highly characterized arrhythmogenic cardiomyopathy cohort with classical and non-classical phenotypes\u2013a real-world assessment of a novel prediction model: does the subtype really matter","volume":"22","author":"Casella","year":"2020","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B38","doi-asserted-by":"publisher","first-page":"e009005","DOI":"10.1161\/CIRCEP.120.009005","article-title":"Characteristics of patients with arrhythmogenic left ventricular cardiomyopathy: combining genetic and histopathologic findings","volume":"13","author":"Casella","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026092119581407600_ehag297-B39","doi-asserted-by":"publisher","first-page":"131447","DOI":"10.1016\/j.ijcard.2023.131447","article-title":"Proposed diagnostic criteria for arrhythmogenic cardiomyopathy: European task force consensus report","volume":"395","author":"Corrado","year":"2024","journal-title":"Int J Cardiol"},{"key":"2026092119581407600_ehag297-B40","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.hrthm.2020.09.015","article-title":"Differentiating hereditary arrhythmogenic right ventricular cardiomyopathy from cardiac sarcoidosis fulfilling 2010 ARVC Task Force Criteria","volume":"18","author":"Gasperetti","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B41","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCEP.113.000932","article-title":"Arrhythmogenic right ventricular dysplasia\/cardiomyopathy and cardiac sarcoidosis: distinguishing features when the diagnosis is unclear","volume":"7","author":"Philips","year":"2014","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026092119581407600_ehag297-B42","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jacc.2008.11.017","article-title":"High prevalence of myocarditis mimicking arrhythmogenic right ventricular cardiomyopathy","volume":"53","author":"Pieroni","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B43","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1093\/eurheartj\/ehv591","article-title":"Electrocardiographic anterior T-wave inversion in athletes of different ethnicities: differential diagnosis between athlete\u2019s heart and cardiomyopathy","volume":"37","author":"Calore","year":"2016","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B44","doi-asserted-by":"publisher","first-page":"e021370","DOI":"10.1161\/JAHA.121.021370","article-title":"Endomyocardial biopsy: the forgotten piece in the arrhythmogenic cardiomyopathy puzzle","volume":"10","author":"Casella","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"2026092119581407600_ehag297-B45","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1016\/j.hrthm.2023.08.035","article-title":"Diagnostic pitfalls in patients referred for arrhythmogenic right ventricular cardiomyopathy","volume":"20","author":"Sampognaro","year":"2023","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B46","doi-asserted-by":"publisher","first-page":"e003047","DOI":"10.1161\/CIRCGEN.120.003047","article-title":"Impact of genetic variant reassessment on the diagnosis of arrhythmogenic right ventricular cardiomyopathy based on the 2010 task force criteria","volume":"14","author":"Costa","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2026092119581407600_ehag297-B47","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.hrthm.2015.08.031","article-title":"High interobserver variability in the assessment of epsilon waves: implications for diagnosis of arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"13","author":"Platonov","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B48","doi-asserted-by":"publisher","first-page":"e003273","DOI":"10.1161\/CIRCGEN.120.003273","article-title":"An international evidence based reappraisal of genes associated with arrhythmogenic right ventricular cardiomyopathy (ARVC) using the clinical genome resource framework","volume":"14","author":"James","year":"2021","journal-title":"Circ Genom Precis Med"},{"key":"2026092119581407600_ehag297-B49","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1093\/europace\/euaa039","article-title":"Diagnosing arrhythmogenic right ventricular cardiomyopathy by 2010 task force criteria: clinical performance and simplified practical implementation","volume":"22","author":"Bosman","year":"2020","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B50","doi-asserted-by":"publisher","first-page":"1080","DOI":"10.1016\/j.hrthm.2024.08.030","article-title":"Improved diagnosis of arrhythmogenic right ventricular cardiomyopathy using electrocardiographic deep learning","volume":"22","author":"Carrick","year":"2025","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B51","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1007\/s11897-024-00688-4","article-title":"Artificial intelligence advancements in cardiomyopathies: implications for diagnosis and management of arrhythmogenic cardiomyopathy","volume":"22","author":"Salavati","year":"2025","journal-title":"Curr Heart Fail Rep"},{"key":"2026092119581407600_ehag297-B52","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1161\/CIRCULATIONAHA.117.030792","article-title":"Risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"136","author":"Calkins","year":"2017","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B53","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.hrthm.2018.01.031","article-title":"Predicting arrhythmic risk in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis","volume":"15","author":"Bosman","year":"2018","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B54","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euad312","article-title":"Arrhythmic risk stratification in arrhythmogenic right ventricular cardiomyopathy","volume":"25","author":"Gasperetti","year":"2023","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B55","doi-asserted-by":"publisher","first-page":"e272","DOI":"10.1161\/CIR.0000000000000549","article-title":"2017 AHA\/ACC\/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines and the heart rhythm society","volume":"138","author":"Al-Khatib","year":"2018","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B56","doi-asserted-by":"publisher","first-page":"3227","DOI":"10.1093\/eurheartj\/ehv162","article-title":"Treatment of arrhythmogenic right ventricular cardiomyopathy\/dysplasia: an international task force consensus statement","volume":"36","author":"Corrado","year":"2015","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B57","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1016\/j.hrthm.2020.03.007","article-title":"Novel risk calculator performance in athletes with arrhythmogenic right ventricular cardiomyopathy","volume":"17","author":"Gasperetti","year":"2020","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B58","doi-asserted-by":"publisher","first-page":"2753","DOI":"10.1016\/j.jacc.2020.04.023","article-title":"Prognostic value of magnetic resonance phenotype in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"75","author":"Aquaro","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B59","doi-asserted-by":"publisher","first-page":"3053","DOI":"10.1093\/eurheartj\/ehac235","article-title":"Importance of genotype for risk stratification in arrhythmogenic right ventricular cardiomyopathy using the 2019 ARVC risk calculator","volume":"43","author":"Protonotarios","year":"2022","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B60","doi-asserted-by":"publisher","first-page":"3041","DOI":"10.1093\/eurheartj\/ehac289","article-title":"Arrhythmic risk prediction in arrhythmogenic right ventricular cardiomyopathy: external validation of the arrhythmogenic right ventricular cardiomyopathy risk calculator","volume":"43","author":"Jord\u00e0","year":"2022","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B61","doi-asserted-by":"publisher","first-page":"e010221","DOI":"10.1161\/CIRCEP.121.010221","article-title":"Integrating exercise into personalized ventricular arrhythmia risk prediction in arrhythmogenic right ventricular cardiomyopathy","volume":"15","author":"Bosman","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026092119581407600_ehag297-B62","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1161\/CIRCULATIONAHA.122.060866","article-title":"Programmed ventricular stimulation as an additional primary prevention risk stratification tool in arrhythmogenic right ventricular cardiomyopathy: a multinational study","volume":"149","author":"Gasperetti","year":"2022","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B63","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1093\/europace\/euab162","article-title":"Comparing clinical performance of current implantable cardioverter-defibrillator implantation recommendations in arrhythmogenic right ventricular cardiomyopathy","volume":"24","author":"Bosman","year":"2022","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B64","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1002\/ehf2.13019","article-title":"Comparison of different prediction models for the indication of implanted cardioverter defibrillator in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"7","author":"Aquaro","year":"2020","journal-title":"ESC Heart Fail"},{"key":"2026092119581407600_ehag297-B65","doi-asserted-by":"publisher","first-page":"3029","DOI":"10.1093\/eurheartj\/ehac298","article-title":"Implantable defibrillators in primary prevention of genetic arrhythmias. A shocking choice?","volume":"43","author":"Corrado","year":"2022","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B66","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1161\/CIRCULATIONAHA.120.046900","article-title":"Diagnostic yield of electroanatomic voltage mapping in guiding endomyocardial biopsies","volume":"143","author":"Casella","year":"2020","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B67","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.119.007611","article-title":"Characterization of structural changes in arrhythmogenic right ventricular cardiomyopathy with recurrent ventricular tachycardia after ablation: insights from repeat electroanatomic voltage mapping","volume":"13","author":"Brice\u00f1o","year":"2020","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026092119581407600_ehag297-B68","doi-asserted-by":"publisher","first-page":"1942","DOI":"10.1093\/eurheartj\/ehr472","article-title":"Electrophysiological abnormalities precede overt structural changes in arrhythmogenic right ventricular cardiomyopathy due to mutations in desmoplakin-A combined murine and human study","volume":"33","author":"Gomes","year":"2012","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B69","doi-asserted-by":"publisher","first-page":"1761","DOI":"10.1016\/j.jacc.2012.11.087","article-title":"Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated desmosomal mutation carriers","volume":"62","author":"te Riele","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B70","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1001\/jamacardio.2021.6016","article-title":"Association of premature ventricular contraction burden on serial holter monitoring with arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"7","author":"Gasperetti","year":"2022","journal-title":"JAMA Cardiol"},{"key":"2026092119581407600_ehag297-B71","doi-asserted-by":"publisher","first-page":"e011207","DOI":"10.1161\/CIRCEP.122.011207","article-title":"Longitudinal prediction of ventricular arrhythmic risk in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"15","author":"Carrick","year":"2022","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026092119581407600_ehag297-B72","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1016\/j.jacc.2013.06.033","article-title":"Exercise increases age-related penetrance and arrhythmic risk in arrhythmogenic right ventricular dysplasia\/cardiomyopathy\u2013associated desmosomal mutation carriers","volume":"62","author":"James","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B73","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1016\/j.jacep.2018.01.010","article-title":"Harmful effects of exercise intensity and exercise duration in patients with arrhythmogenic cardiomyopathy","volume":"4","author":"Lie","year":"2018","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119581407600_ehag297-B74","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1161\/CIRCULATIONAHA.121.057757","article-title":"Exercise causes arrhythmogenic remodeling of intracellular calcium dynamics in plakophilin-2-deficient hearts","volume":"145","author":"van Opbergen","year":"2022","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B75","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1093\/europace\/euaa105","article-title":"Exercise restriction is protective for genotype-positive family members of arrhythmogenic right ventricular cardiomyopathy patients","volume":"22","author":"Wang","year":"2020","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B76","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.hlc.2019.12.007","article-title":"Exercise and arrhythmogenic right ventricular cardiomyopathy","volume":"29","author":"Prior","year":"2020","journal-title":"Heart Lung Circ"},{"key":"2026092119581407600_ehag297-B77","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.114.001471","article-title":"Exercise has a disproportionate role in the pathogenesis of arrhythmogenic right ventricular dysplasia\/cardiomyopathy in patients without desmosomal mutations","volume":"3","author":"Sawant","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"2026092119581407600_ehag297-B78","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1007\/s12471-023-01800-4","article-title":"Exercise does not influence development of phenotype in PLN p.(Arg14del) cardiomyopathy","volume":"31","author":"Van Lint","year":"2023","journal-title":"Neth Heart J"},{"key":"2026092119581407600_ehag297-B79","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.hrthm.2015.08.035","article-title":"Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers","volume":"13","author":"Sawant","year":"2016","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B80","doi-asserted-by":"publisher","first-page":"e008843","DOI":"10.1161\/JAHA.118.008843","article-title":"Impact of exercise restriction on arrhythmic risk among patients with arrhythmogenic right ventricular cardiomyopathy","volume":"7","author":"Wang","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"2026092119581407600_ehag297-B81","doi-asserted-by":"publisher","first-page":"538","DOI":"10.1093\/eurheartj\/ehad799","article-title":"Implantable cardioverter defibrillator use in arrhythmogenic right ventricular cardiomyopathy in North America and Europe","volume":"45","author":"Carrick","year":"2024","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B82","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1136\/heartjnl-2022-321739","article-title":"Evolution and triggers of defibrillator shocks in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"109","author":"Molitor","year":"2023","journal-title":"Heart"},{"key":"2026092119581407600_ehag297-B83","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.ijcard.2021.04.069","article-title":"Antiarrhythmic therapy and risk of cumulative ventricular arrhythmias in arrhythmogenic right ventricle cardiomyopathy","volume":"334","author":"Cappelletto","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026092119581407600_ehag297-B84","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1161\/01.CIR.86.1.29","article-title":"Efficacy of antiarrhythmic drugs in patients with arrhythmogenic right ventricular disease. Results in patients with inducible and noninducible ventricular tachycardia","volume":"86","author":"Wichter","year":"1992","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B85","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.jacc.2009.04.052","article-title":"Efficacy of antiarrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy","volume":"54","author":"Marcus","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B86","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.ijcard.2021.06.009","article-title":"Anti-arrhythmic drugs in arrhythmogenic right ventricular cardiomyopathy: the importance of optimal beta-blocker dose titration","volume":"338","author":"Gasperetti","year":"2021","journal-title":"Int J Cardiol"},{"key":"2026092119581407600_ehag297-B87","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1093\/europace\/euab182","article-title":"Safety and efficacy of flecainide associated with beta-blockers in arrhythmogenic right ventricular cardiomyopathy","volume":"24","author":"Rolland","year":"2022","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B88","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1016\/j.jacep.2025.02.023","article-title":"Long-term follow-up data on flecainide use as an antiarrhythmic in arrhythmogenic right ventricular cardiomyopathy","volume":"11","author":"Gaine","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119581407600_ehag297-B89","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1161\/CIRCULATIONAHA.108.834903","article-title":"Epicardial substrate and outcome with epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"120","author":"Garcia","year":"2009","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B90","doi-asserted-by":"publisher","first-page":"716","DOI":"10.1016\/j.hrthm.2014.12.018","article-title":"Outcomes and ventricular tachycardia recurrence characteristics after epicardial ablation of ventricular tachycardia in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"12","author":"Philips","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B91","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1016\/j.hrthm.2021.04.028","article-title":"Clinical outcomes of catheter ablation of ventricular tachycardia in patients with arrhythmogenic right ventricular cardiomyopathy: insights from the Johns Hopkins ARVC Program","volume":"18","author":"Daimee","year":"2021","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B92","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.ccep.2022.08.004","article-title":"Catheter ablation of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy","volume":"14","author":"Gasperetti","year":"2022","journal-title":"Card Electrophysiol Clin"},{"key":"2026092119581407600_ehag297-B93","doi-asserted-by":"publisher","first-page":"2022","DOI":"10.1111\/jce.14593","article-title":"Endo-epicardial ablation vs endocardial ablation for the management of ventricular tachycardia in arrhythmogenic right ventricular cardiomyopathy: a systematic review and meta-analysis","volume":"31","author":"Romero","year":"2020","journal-title":"J Cardiovasc Electrophysiol"},{"key":"2026092119581407600_ehag297-B94","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.jacc.2022.06.035","article-title":"Clinical outcomes in patients with dilated cardiomyopathy and ventricular tachycardia","volume":"80","author":"Zeppenfeld","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B95","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1016\/j.jacep.2023.11.017","article-title":"Catheter ablation for ventricular tachycardia in patients with desmoplakin cardiomyopathy","volume":"10","author":"Gasperetti","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119581407600_ehag297-B96","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.jacep.2023.11.018","article-title":"Ventricular tachycardia ablation in patients with desmoplakin cardiomyopathy","volume":"10","author":"Ghannam","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119581407600_ehag297-B97","doi-asserted-by":"publisher","first-page":"e013145","DOI":"10.1161\/CIRCEP.124.013145","article-title":"Electrophysiological phenotype-genotype study of sustained monomorphic ventricular tachycardia in inherited, high arrhythmic risk, left ventricular cardiomyopathy","volume":"17","author":"Cabrera-Borrego","year":"2024","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"2026092119581407600_ehag297-B98","doi-asserted-by":"publisher","first-page":"e003819","DOI":"10.1161\/CIRCHEARTFAILURE.116.003819","article-title":"Heart failure is common and under-recognized in patients with arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"10","author":"Gilotra","year":"2017","journal-title":"Circ Heart Fail"},{"key":"2026092119581407600_ehag297-B99","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/eurheartj\/ehae571","article-title":"Clinical features and outcomes in carriers of pathogenic desmoplakin variants","volume":"46","author":"Gasperetti","year":"2025","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B100","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/j.ijcard.2018.06.105","article-title":"A founder homozygous DSG2 variant in east Asia results in ARVC with full penetrance and heart failure phenotype","volume":"274","author":"Chen","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026092119581407600_ehag297-B101","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1002\/ehf2.13757","article-title":"Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experience","volume":"9","author":"Scheel","year":"2022","journal-title":"ESC Heart Fail"},{"key":"2026092119581407600_ehag297-B102","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1161\/CIRCULATIONAHA.125.073919","article-title":"Prognostic role of myocarditis-like episodes and their treatment in patients with pathogenic desmoplakin variants","volume":"152","author":"Gasperetti","year":"2025","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B103","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1007\/s11886-024-02183-7","article-title":"Desmoplakin cardiomyopathy: role of inflammation and potential role of disease-modifying therapies","volume":"27","author":"Gasperetti","year":"2025","journal-title":"Curr Cardiol Rep"},{"key":"2026092119581407600_ehag297-B104","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.jacbts.2023.02.018","article-title":"Multimodal detection and targeting of biopsy-proven myocardial inflammation in genetic cardiomyopathies","volume":"8","author":"Peretto","year":"2023","journal-title":"JACC Basic Transl Sci"},{"key":"2026092119581407600_ehag297-B105","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1161\/CIRCULATIONAHA.121.055890","article-title":"Inflammation and immune response in arrhythmogenic cardiomyopathy: state-of-the-art review","volume":"144","author":"Asatryan","year":"2021","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B106","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.cardfail.2018.03.004","article-title":"Genetic evaluation of cardiomyopathy\u2014a Heart Failure Society of America practice guideline","volume":"24","author":"Hershberger","year":"2018","journal-title":"J Card Fail"},{"key":"2026092119581407600_ehag297-B107","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1093\/eurheartj\/ehz570","article-title":"High penetrance and similar disease progression in probands and in family members with arrhythmogenic cardiomyopathy","volume":"41","author":"Chivulescu","year":"2020","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B108","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jacc.2014.04.044","article-title":"Yield of serial evaluation in at-risk family members of patients with ARVD\/C","volume":"64","author":"te Riele","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B109","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.jacc.2023.05.005","article-title":"Individualized family screening for arrhythmogenic right ventricular cardiomyopathy","volume":"82","author":"Muller","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B110","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1001\/jamacardio.2016.5034","article-title":"Evaluation of structural progression in arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"2","author":"Mast","year":"2017","journal-title":"JAMA Cardiol"},{"key":"2026092119581407600_ehag297-B111","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1136\/hrt.2009.189621","article-title":"Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin","volume":"96","author":"La Gerche","year":"2010","journal-title":"Heart"},{"key":"2026092119581407600_ehag297-B112","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1161\/CIRCULATIONAHA.125.074058","article-title":"Family screening in relatives at risk for plakophilin-2\u2013associated arrhythmogenic right ventricular cardiomyopathy","volume":"152","author":"Muller","year":"2025","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B113","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.1093\/eurheartj\/ehz669","article-title":"Arrhythmogenic right ventricular cardiomyopathy: evaluation of the current diagnostic criteria and differential diagnosis","volume":"41","author":"Corrado","year":"2020","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B114","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1093\/eurheartj\/ehl380","article-title":"Desmoglein-2 mutations in arrhythmogenic right ventricular cardiomyopathy: a genotype-phenotype characterization of familial disease","volume":"28","author":"Syrris","year":"2006","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B115","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1093\/eurjhf\/hfs119","article-title":"Phospholamban R14del mutation in patients diagnosed with dilated cardiomyopathy or arrhythmogenic right ventricular cardiomyopathy: evidence supporting the concept of arrhythmogenic cardiomyopathy","volume":"14","author":"van der Zwaag","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"2026092119581407600_ehag297-B116","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1161\/CIRCGENETICS.114.001003","article-title":"Clinical presentation, long-term follow-up, and outcomes of 1001 arrhythmogenic right ventricular dysplasia\/cardiomyopathy patients and family members","volume":"8","author":"Groeneweg","year":"2015","journal-title":"Circ Cardiovasc Genet"},{"key":"2026092119581407600_ehag297-B117","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1093\/eurheartj\/ehu509","article-title":"Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia\/cardiomyopathy-associated mutation carriers","volume":"36","author":"Bhonsale","year":"2015","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B118","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1093\/eurheartj\/ehaf477","article-title":"Major arrhythmias in non-dilated left ventricular cardiomyopathy: a novel prediction score","volume":"47","author":"Peretto","year":"2026","journal-title":"Eur Heart J"},{"key":"2026092119581407600_ehag297-B119","doi-asserted-by":"publisher","first-page":"133224","DOI":"10.1016\/j.ijcard.2025.133224","article-title":"Arrhythmic risk prediction in non-dilated left ventricular cardiomyopathy: the role of overlap with arrhythmogenic cardiomyopathy","volume":"431","author":"Gueli","year":"2025","journal-title":"Int J Cardiol"},{"key":"2026092119581407600_ehag297-B120","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1002\/ejhf.3168","article-title":"Role of arrhythmic phenotype in prognostic stratification and management of dilated cardiomyopathy","volume":"26","author":"Setti","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"2026092119581407600_ehag297-B121","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1016\/j.jacc.2022.08.804","article-title":"Prognostic prediction of genotype vs phenotype in genetic cardiomyopathies","volume":"80","author":"Paldino","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B122","doi-asserted-by":"publisher","first-page":"1641","DOI":"10.1161\/CIRCULATIONAHA.105.568642","article-title":"Clinical features of arrhythmogenic right ventricular dysplasia\/cardiomyopathy associated with mutations in plakophilin-2","volume":"113","author":"Dalal","year":"2006","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B123","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.jacc.2015.01.045","article-title":"Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2","volume":"65","author":"Cruz","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"2026092119581407600_ehag297-B124","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1136\/jmedgenet-2021-107911","article-title":"Genotype\u2013phenotype correlation in arrhythmogenic right ventricular cardiomyopathy\u2014risk of arrhythmias and heart failure","volume":"59","author":"Christensen","year":"2022","journal-title":"J Med Genet"},{"key":"2026092119581407600_ehag297-B125","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1038\/s41467-017-00127-0","article-title":"Plakophilin-2 is required for transcription of genes that control calcium cycling and cardiac rhythm","volume":"8","author":"Cerrone","year":"2017","journal-title":"Nat Commun"},{"key":"2026092119581407600_ehag297-B126","doi-asserted-by":"publisher","first-page":"e004305","DOI":"10.1161\/CIRCGEN.123.004305","article-title":"AAV-mediated delivery of plakophilin-2a arrests progression of arrhythmogenic right ventricular cardiomyopathy in murine hearts: preclinical evidence supporting gene therapy in humans","volume":"17","author":"Van Opbergen","year":"2024","journal-title":"Circ Genom Precis Med"},{"key":"2026092119581407600_ehag297-B127","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1086\/521633","article-title":"A novel dominant mutation in plakoglobin causes arrhythmogenic right ventricular cardiomyopathy","volume":"81","author":"Asimaki","year":"2007","journal-title":"Am J Hum Genet"},{"key":"2026092119581407600_ehag297-B128","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/j.ijcard.2012.12.078","article-title":"Naxos disease evolution mimicking acute myocarditis: the role of cardiovascular magnetic resonance imaging","volume":"166","author":"Mavrogeni","year":"2013","journal-title":"Int J Cardiol"},{"key":"2026092119581407600_ehag297-B129","doi-asserted-by":"publisher","first-page":"101547","DOI":"10.1016\/j.jacadv.2024.101547","article-title":"Naxos disease and related cardio-cutaneous syndromes","volume":"4","author":"Protonotarios","year":"2025","journal-title":"JACC Adv"},{"key":"2026092119581407600_ehag297-B130","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.hjc.2025.04.004","article-title":"NAXCARE: a clinical outcome registry for Naxos disease and related cardiocutaneous syndromes","volume":"87","author":"Tsatsopoulou","year":"2026","journal-title":"Hellenic J Cardiol"},{"key":"2026092119581407600_ehag297-B131","doi-asserted-by":"publisher","first-page":"e003672","DOI":"10.1161\/CIRCGEN.121.003672","article-title":"Variant location is a novel risk factor for individuals with arrhythmogenic cardiomyopathy due to a desmoplakin (DSP) truncating variant","volume":"16","author":"Hoorntje","year":"2023","journal-title":"Circ Genom Precis Med"},{"key":"2026092119581407600_ehag297-B132","doi-asserted-by":"publisher","first-page":"101867","DOI":"10.1016\/j.jocmr.2025.101867","article-title":"Imaging features of desmoplakin arrhythmogenic cardiomyopathy: a comparative cardiovascular magnetic resonance study","volume":"27","author":"Laredo","year":"2025","journal-title":"J Cardiovasc Magn Reson"},{"key":"2026092119581407600_ehag297-B133","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10554-021-02408-8","article-title":"Cardiac magnetic resonance features of left dominant arrhythmogenic cardiomyopathy: differential diagnosis with myocarditis","volume":"38","author":"Andreini","year":"2022","journal-title":"Int J Cardiovasc Imaging"},{"key":"2026092119581407600_ehag297-B134","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1093\/ehjci\/jez188","article-title":"Dilated cardiomyopathy and arrhythmogenic left ventricular cardiomyopathy: a comprehensive genotype-imaging phenotype study","volume":"21","author":"Augusto","year":"2020","journal-title":"Eur Heart J Cardiovas Imag"},{"key":"2026092119581407600_ehag297-B135","doi-asserted-by":"publisher","first-page":"714","DOI":"10.1016\/j.jchf.2022.06.013","article-title":"Acute myocarditis associated with desmosomal gene variants","volume":"10","author":"Ammirati","year":"2022","journal-title":"JACC Heart Fail"},{"key":"2026092119581407600_ehag297-B136","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1093\/europace\/euaa343","article-title":"\u2018Hot phase\u2019 clinical presentation in arrhythmogenic cardiomyopathy","volume":"23","author":"Bariani","year":"2021","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B137","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jchf.2024.02.012","article-title":"Prevalence of pathogenic variants in cardiomyopathy-associated genes in acute myocarditis","volume":"12","author":"Monda","year":"2024","journal-title":"JACC Heart Fail"},{"key":"2026092119581407600_ehag297-B138","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.hrthm.2015.01.001","article-title":"Genetics of myocarditis in arrhythmogenic right ventricular dysplasia","volume":"12","author":"Lopez-Ayala","year":"2015","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B139","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.ijcard.2018.10.083","article-title":"Prevalence of 18F-fluorodeoxyglucose positron emission tomography abnormalities in patients with arrhythmogenic right ventricular cardiomyopathy","volume":"284","author":"Protonotarios","year":"2019","journal-title":"Int J Cardiol"},{"key":"2026092119581407600_ehag297-B140","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1093\/europace\/euab183","article-title":"Clinical characteristics and risk stratification of desmoplakin cardiomyopathy","volume":"24","author":"Wang","year":"2022","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B141","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jaccas.2021.10.005","article-title":"Management of recurrent myocarditis due to desmoplakin cardiomyopathy: diagnostic and therapeutic challenges","volume":"4","author":"Ghawanmeh","year":"2022","journal-title":"JACC Case Rep"},{"key":"2026092119581407600_ehag297-B142","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.jacep.2025.02.025","article-title":"Intercalated disc abnormalities are linked to arrhythmias in inflammatory cardiomyopathy","volume":"11","author":"Peretto","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119581407600_ehag297-B143","doi-asserted-by":"publisher","first-page":"100832","DOI":"10.1016\/j.jacadv.2024.100832","article-title":"Long-term arrhythmic follow-up and risk stratification of patients with desmoplakin-associated arrhythmogenic right ventricular cardiomyopathy","volume":"3","author":"Gasperetti","year":"2024","journal-title":"JACC Adv"},{"key":"2026092119581407600_ehag297-B144","doi-asserted-by":"publisher","first-page":"1626242","DOI":"10.3389\/fcell.2025.1626242","article-title":"Genetic landscape of phospholamban cardiomyopathies","volume":"13","author":"Vafiadaki","year":"2025","journal-title":"Front Cell Dev Biol"},{"key":"2026092119581407600_ehag297-B145","doi-asserted-by":"publisher","first-page":"3269","DOI":"10.1002\/ejhf.3672","article-title":"Age-related penetrance of phospholamban p.Arg14del cardiomyopathy","volume":"27","author":"Verstraelen","year":"2025","journal-title":"Eur J Heart Fail"},{"key":"2026092119581407600_ehag297-B146","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae069","article-title":"Long-term reliability of the phospholamban (PLN) p.(Arg14del) risk model in predicting major ventricular arrhythmia: a landmark study","volume":"26","author":"van der Heide","year":"2024","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B147","doi-asserted-by":"publisher","first-page":"102558","DOI":"10.1016\/j.jchf.2025.102558","article-title":"Identifying predictors for heart failure outcomes in phospholamban p.(Arg14del)\u2013positive individuals","volume":"13","author":"van der Heide","year":"2025","journal-title":"JACC Heart Fail"},{"key":"2026092119581407600_ehag297-B148","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1086\/509044","article-title":"Mutant desmocollin-2 causes arrhythmogenic right ventricular cardiomyopathy","volume":"79","author":"Heuser","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2026092119581407600_ehag297-B149","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1086\/504393","article-title":"DSG2 mutations contribute to arrhythmogenic right ventricular dysplasia\/cardiomyopathy","volume":"79","author":"Awad","year":"2006","journal-title":"Am J Hum Genet"},{"key":"2026092119581407600_ehag297-B150","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1002\/ejhf.1423","article-title":"High risk of heart failure associated with desmoglein-2 mutations compared to plakophilin-2 mutations in arrhythmogenic right ventricular cardiomyopathy\/dysplasia","volume":"21","author":"Hermida","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"2026092119581407600_ehag297-B151","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1093\/europace\/euq104","article-title":"Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia\/cardiomyopathy: spectrum of mutations and clinical impact in practice","volume":"12","author":"Fressart","year":"2010","journal-title":"Europace"},{"key":"2026092119581407600_ehag297-B152","doi-asserted-by":"publisher","first-page":"1595","DOI":"10.1161\/circulationaha.117.028719","article-title":"Novel desmin mutation p.Glu401Asp impairs filament formation, disrupts cell membrane integrity, and causes severe arrhythmogenic left ventricular cardiomyopathy\/dysplasia","volume":"137","author":"Berm\u00fadez-Jim\u00e9nez","year":"2018","journal-title":"Circulation"},{"key":"2026092119581407600_ehag297-B153","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1016\/j.hrthm.2009.07.041","article-title":"Severe cardiac phenotype with right ventricular predominance in a large cohort of patients with a single missense mutation in the DES gene","volume":"6","author":"van Tintelen","year":"2009","journal-title":"Heart Rhythm"},{"key":"2026092119581407600_ehag297-B154","doi-asserted-by":"publisher","first-page":"1178","DOI":"10.1016\/j.jacep.2024.02.031","article-title":"Phenotype and clinical outcomes in desmin-related arrhythmogenic cardiomyopathy","volume":"10","author":"Bermudez-Jimenez","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"2026092119581407600_ehag297-B155","doi-asserted-by":"publisher","first-page":"e004878","DOI":"10.1161\/circgen.124.004878","article-title":"Natural history, phenotype spectrum, and clinical outcomes of desmin (DES)-associated cardiomyopathy","volume":"18","author":"Asatryan","year":"2025","journal-title":"Circ Genom Precis Med"},{"key":"2026092119581407600_ehag297-B156","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1111\/j.1399-0004.2012.01919.x","article-title":"The natural history of a genetic subtype of arrhythmogenic right ventricular cardiomyopathy caused by a p.S358L mutation in TMEM43","volume":"83","author":"Hodgkinson","year":"2013","journal-title":"Clin Genet"}],"container-title":["European Heart Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/36\/5072\/68478782\/ehag297.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eurheartj\/article-pdf\/47\/36\/5072\/68478782\/ehag297.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T23:58:20Z","timestamp":1790035100000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eurheartj\/article\/47\/36\/5072\/8702771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,5]]},"references-count":156,"journal-issue":{"issue":"36","published-online":{"date-parts":[[2026,6,5]]},"published-print":{"date-parts":[[2026,9,22]]}},"URL":"https:\/\/doi.org\/10.1093\/eurheartj\/ehag297","relation":{},"ISSN":["0195-668X","1522-9645"],"issn-type":[{"value":"0195-668X","type":"print"},{"value":"1522-9645","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,9,21]]},"published":{"date-parts":[[2026,6,5]]}}}